Testsealabs Chlamydia Trachomatis Ag Test
Short Description:
The Chlamydia Trachomatis Ag Test is a rapid chromatographic immunoassay for the qualitative detection of chlamydia trachomatis in male urethral swab and female cervical swab to aid in the diagnosis of chlamydia trachomatis infection.
Fast & Accurate：Achieve reliable results in minutes.
Simple Operation：No complex equipment required.
High Accuracy：Lab-grade precision you can trust.
Clear Visual Readout：Results are easy to read and interpret.
Certified Quality Systems：Compliant with ISO 13485 and MDSAP.
Room-Temperature Stability：No cold chain needed—easy to transport and store.
Product Specification
| Principle | Chromatographic Immunoassay | Specimen | Male Urethral Swab/Female Cervical |
| Reading Time | 15 minutes | QMS Certification | ISO 13485 and MDSAP |
| Storage Temperature | 4-30°C | Shelf life | 2 years |
| Format | Cassette | Specification | 1T/25T |
Intended Use
The Chlamydia Trachomatis Ag Test is a rapid chromatographic immunoassay for the qualitative detection of chlamydia trachomatis in male urethral swab and female cervical swab to aid in the diagnosis of chlamydia trachomatis infection.
Summary
Chlamydia Trachomatis Core Information Chlamydia trachomatis is the most common cause of sexually transmitted infection worldwide. It consists of elementary bodies (the infectious form) and reticulate or inclusion bodies (the replicating form). Chlamydia trachomatis has both a high prevalence and asymptomatic carriage rate, with frequent serious complications in both women and neonates. In women, complications of chlamydia infection include cervicitis, urethritis, endometritis, pelvic inflammatory disease (PID), as well as an increased incidence of ectopic pregnancy and infertility. Vertical transmission of the disease from mother to neonate during parturition can result in inclusion conjunctivitis and pneumonia. In men, complications include urethritis and epididymitis. At least 40% of nongonococcal urethritis cases are associated with chlamydia infection. Approximately 70% of women with endocervical infections and up to 50% of men with urethral infections are asymptomatic. Traditionally, chlamydia infection has been diagnosed by detecting chlamydia inclusions in tissue culture cells. The culture method is the most sensitive and specific laboratory technique but is labor-intensive, expensive, time-consuming (48-72 hours), and not routinely available in most institutions. The Chlamydia Trachomatis Ag Test is a rapid diagnostic tool that qualitatively detects chlamydia antigen from clinical specimens, providing results in 15 minutes. The test utilizes chlamydia-specific antibodies to selectively identify chlamydia antigen in clinical samples.
